Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Viactiv Helps Boost Bristol Adult Nutritionals 41% In First Quarter

This article was originally published in The Tan Sheet

Executive Summary

Bristol-Myers Squibb's Viactiv Soft Calcium Chews brand is on target to double its sales in 2000 based on first quarter sales of $15 mil. The product garnered $29 mil. in sales in 1999, its first year on the market.

You may also be interested in...



Viactiv Bars, Drinks TV Ad Stresses Energy Benefits For Women

Viactiv snack bars and drinks contain energy "to go" and "nutrients a woman's body craves," Mead Johnson says in a TV commercial supporting the product line extensions.

Excedrin Migraine Full Migraine Indication Approved By FDA

Bristol-Myers Squibb's Excedrin Migraine indication for full migraine syndrome was approved by FDA Oct. 7. The new labeling simply bears the indication "Treats migraine."

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS091135

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel